Teva Pharmaceutical Industries Ltd (WBO:TEVA)
€ 31.6 (0%) Market Cap: 36.82 Bil Enterprise Value: 48.22 Bil PE Ratio: 61.10 PB Ratio: 5.51 GF Score: 45/100

Teva Pharmaceutical Industries Limited at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2026 / 12:30PM GMT
Release Date Price: €31.6
Unidentified Participant

So before we get started, please note that this presentation is for Morgan Stanley institutional clients and employees. For all important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your MS sales rep, and I apologize for how many times I am going to say that over the next three days.

Questions & Answers

Unidentified Participant

So perhaps we get started. Richard, before we go into detail, perhaps you could start with introductory comments as to where we are in the Teva story today, progress on the Pivot to Growth strategy, and the outlook from here.

Richard Francis
Teva Pharmaceutical Industries Limited - President, Chief Executive Officer, Director

Okay. I will try and be brief because obviously I could spend the whole time talking about that. Where we are in the story, to answer that first

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot